Quest Diagnostics sees uptick in COVID-19 testing as Delta variant spreads
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Quest Diagnostics (DGX) PT Raised to $160 at Jefferies
July 23, 2021 8:44 AM EDTJefferies analyst Brian Tanquilut raised the price target on Quest Diagnostics (NYSE: DGX) to $160.00 (from $155.00) while maintaining a Buy rating.
The analyst commented, "e are positive on DGX given our view that continued improvement in core fundamentals -- driven by accelerating payor-driven... More
